| Date | Form | Description | Docs | XBRL | Pages |
| 04/04/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/03/17 | UPLOAD | SEC-generated letter |
|
1 | |
| 03/31/17 | S-3 | Registration statement for specified transactions by certain issuers |
|
50 | |
| 03/27/17 | RW | Registration Withdrawal Request |
|
1 | |
| 03/16/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 03/08/17 | 8-K | Current report filing |
|
34 | |
| 03/06/17 | 424B2 | Prospectus filed pursuant to Rule 424(b)(2) |
|
79 | |
| 02/14/17 | 8-K | Current report filing |
|
6 | |
| 02/01/17 | CT ORDER | Confidential treatment order |
|
1 | |
| 01/27/17 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
|
82 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...